Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

NHS National Pharmaceuticals -- Fulvestrant, Darunavir and Imatinib

The NHS Commissioning Board (operating under the name of NHS England)

This public procurement record has 1 release in its history.

Award

04 Mar 2021 at 10:27

Award Notice
Summary of the contracting process

The procurement process involves the NHS Commissioning Board, operating as NHS England, seeking suppliers for pharmaceutical products under the title "NHS National Pharmaceuticals — Fulvestrant, Darunavir and Imatinib." This tender was initiated through an open procedure and has already reached the award stage, with key dates indicating potential product call-offs commencing as soon as possible and ending by October 31, 2021. The procurement falls within the goods category and is classified under the CPV code 33600000, indicating its focus on pharmaceuticals.

This tender presents an excellent opportunity for businesses in the pharmaceutical sector, particularly those offering products similar to Fulvestrant, Darunavir, and Imatinib. Companies of various sizes, ranging from large-scale suppliers to small and medium enterprises (SMEs), can compete effectively, especially those capable of providing the required goods within the specified timelines. The flexibility of a framework agreement allows for extended partnerships, enhancing the long-term growth potential for successful bidders in a critical healthcare market.

How relevant is this notice?

Notice Information

Notice Title

NHS National Pharmaceuticals -- Fulvestrant, Darunavir and Imatinib

Notice Description

Project title: invitation to offer for NHS National Pharmaceuticals - Fulvestrant, Darunavir and Imatinib Offer reference number: CM/PHG/20/5627Period of framework agreement: start date to be confirmed with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months potential periods of call-offs under the framework agreement: Fulvestrant: All regions: to commence as soon as possible with an end date of 1 May 2021 Darunavir: CESW Region: to commence as soon as possible with an end date of 1 May 2021 Imatinib: All regions: to commence as soon as possible with an end date of 31 October 2021.

Lot Information

Lot 1

Project title: invitation to offer for NHS National Pharmaceuticals - Fulvestrant, Darunavir and Imatinib Offer reference number: CM/PHG/20/5627Period of framework agreement: start date to be confirmed with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months potential periods of call-offs under the framework agreement: Fulvestrant: All regions: to commence as soon as possible with an end date of 1 May 2021 Darunavir: CESW Region: to commence as soon as possible with an end date of 1 May 2021 Imatinib: All regions: to commence as soon as possible with an end date of 31 October 2021. Additional information: Price is not the only award criterion and all criteria are stated in the procurement documents.

Options: Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months potential periods of call-offs under the framework agreement.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-029839
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/004316-2021
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
£1

Notice Dates

Publication Date
4 Mar 20215 years ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
15 Jan 20215 years ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Cancelled
Awards Status
Active
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
The NHS Commissioning Board (operating under the name of NHS England)
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
RUNCORN
Postcode
WA7 2ES
Postcode Area
Warrington
Country
England
Major Region (ITL 1)
TLD North West (England)
Basic Region (ITL 2)
TLD7 Merseyside
Small Region (ITL 3)
TLD71 East Merseyside
Delivery Location
Not specified
Local Authority
Halton
Electoral Ward
Halton Lea
Westminster Constituency
Runcorn and Helsby

Supplier Information

Number of Suppliers
10
Supplier Names

Accord-UK Ltd

THORNTON & ROSS LIMITED

Zentiva Pharma UK Ltd

ASTRAZENECA UK LIMITED

Cipla (EU) Limited

Dr.Reddy's Laboratories (UK) Limited

Janssen-Cilag Ltd

Sandoz Ltd

Teva UK Limited

Novartis Pharmaceuticals UK Limited

Further Information

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...